CGIX


Why Cancer Genetics (CGIX) Is Skyrocketing Today

Shares soar after the company notches an important regulatory win.

Feltl and Company’s Top Ideas For The Second Half Of 2014

Today, numerous analysts at Feltl and Company provided their inputs for what they think are the best Buys this year. The first report comes from analyst Mark …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts